Chinese Journal of Tissue Engineering Research ›› 2025, Vol. 29 ›› Issue (7): 1321-1327.doi: 10.12307/2024.741

    Next Articles

Mechanism by which nobiletin inhibits inflammatory response of BV2 microglia

Chi Wenxin1, 2, Zhang Cunxin2, Gao Kai3, Lyu Chaoliang2, Zhang Kefeng2   

  1. 1School of Clinical Medicine, Jining Medical University, Jining 272067, Shandong Province, China; 2Department of Spine Surgery, 3Department of Joint Surgery, Jining No. 1 People’s Hospital, Jining 272000, Shandong Province, China
  • Received:2023-08-21 Accepted:2023-12-14 Online:2025-03-08 Published:2024-06-27
  • Contact: Zhang Kefeng, Master, Associate chief physician, Department of Spine Surgery, Jining No. 1 People’s Hospital, Jining 272000, Shandong Province, China; Lyu Chaoliang, MD, Chief physician, Department of Spine Surgery, Jining No. 1 People’s Hospital, Jining 272000, Shandong Province, China
  • About author:Chi Wenxin, Master candidate, School of Clinical Medicine, Jining Medical University, Jining 272067, Shandong Province, China; Department of Spine Surgery, Jining No. 1 People’s Hospital, Jining 272000, Shandong Province, China
  • Supported by:
    Natural Science Foundation of Shandong Province, No. ZR2021LZY008 (to GK); Jining Key Research & Development Program Project, No. 2021YXNS137 (to GK); Jining Key Research & Development Program Project, No. 2021YXNS001 (to LCL)

Abstract: BACKGROUND: Nobiletin has been found to improve lipopolysaccharide-induced abnormal activation of microglia, excessive release of inflammatory factors and redox imbalance. However, the specific mechanism is not fully understood.

OBJECTIVE: To investigate the molecular mechanism by which nobiletin can inhibit lipopolysaccharide-induced inflammation in BV2 microglia.  
METHODS: Passage 3 BV2 microglia were divided into three groups: control group was cultured for 24 hours (without any treatment). Lipopolysaccharide group was treated with 10 μg/mL lipopolysaccharide for 24 hours. Lipopolysaccharide + nobiletin group was treated with 20 μmol/L nobiletin for 6 hours and then 10 μg/mL lipopolysaccharide for 24 hours. After the processing, cell proliferation was detected by CCK-8 assay. The level of intracellular reactive oxygen species was detected by fluorescent probe. The mRNA expression levels of nuclear factor κB p65, tumor necrosis factor α, and interleukin-1β were detected by qRT-PCR. The protein expression levels of nuclear factor κB p65, p-nuclear factor κB p65, tumor necrosis factor α, and interleukin-1β were detected by western blot assay.
RESULTS AND CONCLUSION: (1) Compared with the control group, the proliferation activity of lipopolysaccharide group was decreased (P < 0.001). Compared with the lipopolysaccharide group, the cell proliferation activity of lipopolysaccharide + nobiletin group was increased (P < 0.001). (2) Compared with the control group, the level of intracellular reactive oxygen species was increased in the lipopolysaccharide group (P < 0.001). Compared with the lipopolysaccharide group, the level of intracellular reactive oxygen species was decreased in the lipopolysaccharide + nobiletin group (P < 0.01). (3) Compared with the control group, the mRNA expression levels of tumor necrosis factor α and interleukin-1β were increased in the lipopolysaccharide group (P < 0.001, P < 0.01). Compared with the lipopolysaccharide group, mRNA expression levels of tumor necrosis factor α and interleukin-1β were decreased in the lipopolysaccharide + nobiletin group (P < 0.01, P < 0.05). (4) Compared with the control group, the protein expression levels of p-nuclear factor κB p65, tumor necrosis factor α, and interleukin-1β in were increased the lipopolysaccharide group (P < 0.001). Compared with the lipopolysaccharide group, the expression of p-nuclear factor κB p65, tumor necrosis factor α, and interleukin-1β was decreased in the lipopolysaccharide + nobiletin group (P < 0.001). (5) These findings suggest that nobiletin attenuates lipopolysaccharide-induced inflammatory response in BV2 microglia by suppressing nuclear factor-κB signaling pathway.

Key words: nobiletin, nuclear factor-κB, microglia, lipopolysaccharide, spinal cord injury, cell proliferation, reactive oxygen species, inflammatory factor

CLC Number: